Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.6	4.93	12.07	54.74	40.77
Cash & Short-Term Investments	6.6	4.93	12.07	54.74	40.77
Cash Growth	34.01%	-59.16%	-77.95%	34.25%	56.35%
Receivables	-	-	0.07	0.02	0.02
Prepaid Expenses	0.87	0.45	1.15	0.98	1.8
Total Current Assets	7.47	5.38	13.29	55.73	42.6
Total Assets	7.47	5.38	13.29	55.73	42.6
Accounts Payable	6.09	6.57	11.54	16.14	3.44
Accrued Expenses	12.35	11.14	9.79	9.61	3.39
Other Current Liabilities	1.66	0.71	11.45	0.23	0.39
Total Current Liabilities	20.1	18.43	32.77	25.98	7.22
Total Liabilities	20.1	18.43	32.77	25.98	7.22
Common Stock	0.01	0	0	0	0.01
Additional Paid-In Capital	350.31	297.86	241.12	223.01	173.95
Retained Earnings	-370.57	-314.33	-262.49	-199.86	-143.19
Comprehensive Income & Other	7.64	3.42	1.89	6.6	4.62
Shareholders' Equity	-12.63	-13.05	-19.48	29.75	35.38
Total Liabilities & Equity	7.47	5.38	13.29	55.73	42.6
Net Cash (Debt)	6.6	4.93	12.07	54.74	40.77
Net Cash Growth	34.01%	-59.16%	-77.95%	34.25%	56.35%
Net Cash Per Share	0.17	0.18	1.17	6.47	7.30
Filing Date Shares Outstanding	83.76	35.69	12.95	9.06	7.52
Total Common Shares Outstanding	54.34	27.74	10.29	8.46	6.94
Working Capital	-12.63	-13.05	-19.48	29.75	35.38
Book Value Per Share	-0.23	-0.47	-1.89	3.52	5.10
Tangible Book Value	-12.63	-13.05	-19.48	29.75	35.38
Tangible Book Value Per Share	-0.23	-0.47	-1.89	3.52	5.10

Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q